AI-curated court updates, legal developments, and practice-area insights for Indian legal professionals.
The Delhi High Court in Intra Cellular Therapies v. Controller of Patents addressed pivotal issues in pharmaceutical patent law concerning disclosure in genus-species claims and therapeutic efficacy under Section 3(d). The ruling highlights both advancements and shortcomings in the Court's analysis relevant for practitioners in patent law.
The GSTAT has upheld a demand for ₹4.72 lakh against cinema operators, asserting that ticket prices must reflect the GST rate reduction from 18% to 12%.
The GSTAT has ordered Laureate Buildwell to disburse ₹14.95 lakh in ITC benefits to its customers following a DGAP investigation into anti-profiteering practices.
The GSTAT ruling on Bhandari Scrap and Safecon affirms clarifications on GST ITC eligibility, particularly regarding supplier tax defaults and the applicability of Section 74 for fraud proceedings.
The Reserve Bank of India has updated four entries in the UNSC sanctions list related to ISIL and Al-Qaida. This update mandates all regulated entities to comply with the provisions of Section 51A of the Unlawful Activities (Prevention) Act.
The Calcutta High Court ruled that a Cash Credit (CC) or Overdraft (OD) account cannot be classified as a Non-Performing Asset (NPA) unless it meets the specific criteria of being overdue for 90 days or marked
ITAT ruled that a subsidy from an associated enterprise qualifies as operating revenue, removing a TP adjustment.
The Securities and Exchange Board of India (SEBI) has proposed new settlement regulations aiming to simplify the settlement mechanism and lower the settlement amounts involved. Public comments on these proposals are invited until September 4, 2026.
The Securities and Exchange Board of India (SEBI) has modified the Operational Guidelines for the OBPP Framework to allow inclusion of IFSCA products and 54EC bonds. These changes are effective immediately and introduce new compliance requirements.
The Delhi High Court's ruling in *Home Box Office Inc. v. Streamzy.To* provides insights into the dynamics of injunctions and web blocking, framing the ongoing legal discourse on copyright and digital rights.
The Delhi High Court, in *Intra Cellular Therapies v. Controller of Patents*, discussed key issues in pharmaceutical patent law, particularly around Section 3(d) and the coverage disclosure distinction in genus-species claims. The court’s interpretation raises questions about novelty and inventive step.
The ITAT Bangalore has employed turnover and related party transaction (RPT) filters to exclude certain comparables, while still allowing a Section 10A deduction ahead of offsetting non-10A losses.
The ITAT Mumbai has partially allowed Red Hat India's appeal, remitting transfer pricing issues while permitting working capital adjustments and removing the unearned revenue addition.